Shanghai Haohai Biological Technology Co., Ltd. (6826.HK)
HKD 26.85
(-1.65%)
HKD 26.85
(-1.65%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 526.17 Million CNY | 8.44% |
| 2022 | 485.23 Million CNY | 36.78% |
| 2021 | 354.76 Million CNY | 39.05% |
| 2020 | 255.12 Million CNY | 6.31% |
| 2019 | 239.98 Million CNY | 21.43% |
| 2018 | 197.63 Million CNY | 12.99% |
| 2017 | 174.91 Million CNY | 48.29% |
| 2016 | 117.95 Million CNY | 51.1% |
| 2015 | 78.06 Million CNY | 2.22% |
| 2014 | 76.36 Million CNY | 79.24% |
| 2013 | 42.6 Million CNY | 4.26% |
| 2012 | 40.86 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 504.21 Million CNY | -5.52% |
| 2024 Q1 | 533.64 Million CNY | 1.42% |
| 2023 Q3 | 565.13 Million CNY | 5.07% |
| 2023 FY | 526.17 Million CNY | 8.44% |
| 2023 Q1 | 537.88 Million CNY | 10.85% |
| 2023 Q2 | 537.88 Million CNY | 0.0% |
| 2023 Q4 | 526.17 Million CNY | -6.89% |
| 2022 Q4 | 485.23 Million CNY | 0.0% |
| 2022 Q3 | 485.23 Million CNY | 18.21% |
| 2022 Q2 | 410.48 Million CNY | 0.0% |
| 2022 Q1 | 410.48 Million CNY | 15.71% |
| 2022 FY | 485.23 Million CNY | 36.78% |
| 2021 Q1 | 264.05 Million CNY | 3.5% |
| 2021 Q2 | 264.05 Million CNY | -0.0% |
| 2021 Q3 | 314.6 Million CNY | 19.15% |
| 2021 Q4 | 354.76 Million CNY | 12.76% |
| 2021 FY | 354.76 Million CNY | 39.05% |
| 2020 Q3 | 280.84 Million CNY | -2.84% |
| 2020 FY | 255.12 Million CNY | 6.31% |
| 2020 Q1 | - CNY | -100.0% |
| 2020 Q4 | 255.12 Million CNY | -9.16% |
| 2020 Q2 | 289.03 Million CNY | 0.0% |
| 2019 Q4 | 239.98 Million CNY | 0.0% |
| 2019 FY | 239.98 Million CNY | 21.43% |
| 2019 Q2 | 224.14 Million CNY | 0.0% |
| 2019 Q1 | - CNY | -100.0% |
| 2018 Q2 | 184.75 Million CNY | 0.0% |
| 2018 Q4 | 197.63 Million CNY | 0.0% |
| 2018 Q1 | 184.75 Million CNY | 5.63% |
| 2018 Q3 | 197.63 Million CNY | 6.97% |
| 2018 FY | 197.63 Million CNY | 12.99% |
| 2017 Q3 | 174.91 Million CNY | 21.15% |
| 2017 FY | 174.91 Million CNY | 48.29% |
| 2017 Q1 | 144.38 Million CNY | 22.41% |
| 2017 Q2 | 144.38 Million CNY | 0.0% |
| 2017 Q4 | 174.91 Million CNY | 0.0% |
| 2016 Q1 | 66.2 Million CNY | -15.19% |
| 2016 Q3 | 117.95 Million CNY | 78.17% |
| 2016 Q2 | 66.2 Million CNY | 0.0% |
| 2016 FY | 117.95 Million CNY | 51.1% |
| 2016 Q4 | 117.95 Million CNY | 0.0% |
| 2015 Q3 | 78.06 Million CNY | -5.05% |
| 2015 Q2 | 82.21 Million CNY | 0.0% |
| 2015 Q1 | 82.21 Million CNY | 7.66% |
| 2015 FY | 78.06 Million CNY | 2.22% |
| 2015 Q4 | 78.06 Million CNY | 0.0% |
| 2014 Q1 | 57.76 Million CNY | 35.58% |
| 2014 FY | 76.36 Million CNY | 79.24% |
| 2014 Q3 | 76.36 Million CNY | 32.2% |
| 2014 Q2 | 57.76 Million CNY | 0.0% |
| 2014 Q4 | 76.36 Million CNY | 0.0% |
| 2013 Q3 | 42.6 Million CNY | 0.0% |
| 2013 Q4 | 42.6 Million CNY | 0.0% |
| 2013 Q1 | - CNY | 0.0% |
| 2013 FY | 42.6 Million CNY | 4.26% |
| 2012 FY | 40.86 Million CNY | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Uni-Bio Science Group Limited | 36.39 Million HKD | -1345.851% |
| CK Life Sciences Int'l., (Holdings) Inc. | 1.2 Billion HKD | 56.317% |